US

Lynne M Georgopoulos

This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lynne M Georgopoulos. Retrieved from https://idiyas.com/inventor/lynne-m-georgopoulos-bpdgvasx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Lynne M Georgopoulos: Innovator in Hypertension Treatment

Introduction

Lynne M Georgopoulos is an accomplished inventor based in the United States. She has made significant contributions to the field of hypertension treatment through her innovative research and development efforts.

Latest Patents

Lynne holds a patent titled "Use Of Modified Vasoactive Intestinal Peptides In The Treatment Of Hypertension." This invention is based on the discovery that a vasoactive intestinal peptide (VIP) with a binding preference for VPAC2 can provide long-acting blood pressure control when used synergistically with other anti-hypertensive therapies. The methods and compositions she developed are useful for the treatment and amelioration of hypertension.

Career Highlights

Lynne is currently employed at PhaseBio Pharmaceuticals, Inc., where she continues to work on innovative solutions for hypertension. Her dedication to research and development has positioned her as a key player in the pharmaceutical industry.

Collaborations

Lynne collaborates with various professionals in her field, including her coworker Susan Arnold, who is also a woman. Their combined expertise contributes to the advancement of treatments for hypertension.

Conclusion

Lynne M Georgopoulos is a notable inventor whose work in hypertension treatment showcases her commitment to improving patient outcomes. Her innovative approaches and collaborations highlight the importance of research in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…